Generation of aptamers for the selective detection and neutralization of soluble lymphotoxin alpha
Authors:
- Matthew StephensMSMatthew Stephens
- Eman NassefENEman Nassef
- Pierre-Yves von der WeidPWPierre-Yves von der Weid
Open Access
- 17 February 2026
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (1)
Abstract
No abstract availableKeywords
Funding Information
- University of Calgary
- Cumming School of Medicine, University of Calgary
This publication has 45 references indexed in Scilit:
- Lymphotoxin α/β and Tumor Necrosis Factor Are Required for Stromal Cell Expression of Homing Chemokines in B and T Cell Areas of the SpleenJournal of Experimental Medicine, 1999
- TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesisAPMIS, 1997
- Lymphotoxin β Receptor Triggering Induces Activation of the Nuclear Factor κB Transcription Factor in Some Cell TypesJournal of Biological Chemistry, 1996
- Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)Gastroenterology, 1995
- Lymphotoxin ?, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surfaceCell, 1993
- A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.Journal of Experimental Medicine, 1991
- Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin)Protein Engineering, Design and Selection, 1991
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Cachectin (Tumor Necrosis Factor): A Macrophage Hormone Governing Cellular Metabolism and Inflammatory ResponseEndocrine Reviews, 1988